Associations between PM2.5 exposure and infant growth: A mediation analysis of oral microbiota

Huaying Wu1, Chao Dong2, Wenwen Xiao2

  • 1Department of Stomatology, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing 210004, China.

Abstract

Insights

Fine particulate matter (PM$_{2.5}$) exposure can stunt infant growth, potentially by altering oral microbiota. Specific bacteria and co-abundance groups (CAGs) were identified as mediators in this relationship.

Area of Science:

  • Environmental Health
  • Microbiology
  • Pediatrics

Background:

  • Previous research links fine particulate matter (PM$_{2.5}$) exposure to growth retardation in infants.
  • The role of oral microbiota in this association remains underexplored.
  • This study investigates the potential mediating role of oral microbiota in the relationship between PM$_{2.5}$ exposure and infant growth.

Purpose of the Study:

  • To examine the association between ambient PM$_{2.5}$ exposure and infant growth indicators.
  • To identify specific oral microbiota profiles associated with infant growth.
  • To determine if oral microbiota mediates the effect of PM$_{2.5}$ on infant growth.

Main Methods:

  • Collected baseline data from 335 mother-child pairs.
  • Assessed infant growth (weight, length z-scores) and oral microbiota using 16S rRNA gene sequencing.
  • Quantified PM$_{2.5}$ levels using inverse distance weighting and employed regression and mediation analyses.

Main Results:

  • Increased PM$_{2.5}$ exposure (10th month-exam) was linked to decreased infant length z-scores.
  • Specific oral microbiota, including CAG4, correlated with higher weight and BMI z-scores.
  • PM$_{2.5}$ exposure (birth-3rd month) affected weight and BMI z-scores by altering the abundance of the bacterium *Megasphaera*.

Conclusions:

  • PM$_{2.5}$ exposure during infancy can impede linear growth.
  • PM$_{2.5}$ exposure may influence the oral microbiome composition in one-year-old infants.
  • *Megasphaera* may act as a key mediator linking early-life PM$_{2.5}$ exposure to infant weight and BMI outcomes.